GHK-Cu: what the evidence actually shows
GHK-Cu is a copper complex of the tripeptide glycyl-L-histidyl-L-lysine, used topically in cosmetic formulations.
Also known as copper peptide, copper tripeptide-1, GHK.
Evidence and regulatory status
Animal or laboratory evidence only. No published human trial.
Sold as a cosmetic ingredient. Not approved by the FDA as a drug for any indication.
Half-life
No published human pharmacokinetic study reports a half-life for GHK-Cu. Figures circulating on vendor and forum pages are not traceable to a human trial, so this page does not repeat them.
What published trials used
No published human dosing trial exists for GHK-Cu.
Reported for reference only. What a trial administered under supervision is not a recommendation, and Gireta does not make one.
How much research exists
- PubMed records
- 180
- Tagged human
- 65
- Clinical trials
- 3
A PubMed search for GHK-Cu returns 180 records, of which 65 are tagged as human research and 3 are typed as a clinical trial.
Counted on . Counts drift, so the exact query is linked rather than described, and you can re-run it.
Common questions
- Is GHK-Cu FDA approved?
- GHK-Cu appears in cosmetic products, which are regulated differently from drugs and are not approved by the FDA for an indication. It has no drug approval.
- What kind of research exists on GHK-Cu?
- Most of the published work is laboratory and cell-culture research on gene expression and wound healing. Three records are typed as clinical trials, which is a small human literature for a widely sold ingredient.
- What is the half-life of GHK-Cu?
- No published human pharmacokinetic study reports a half-life for GHK-Cu, so this page does not state one. It is applied topically rather than injected, which is a different absorption question again.
Sources
- GHK in skin regeneration · BioMed Research International, via PubMed, 2015
Related compounds
Others graded preclinical here
Held to the same standard on this site. Each page prints its own literature counts, so where a record is typed as a clinical trial you can see it rather than take our word for the grade.
Planning a schedule?
Gireta turns a compound and a cadence into a twelve-week timeline with the reconstitution maths worked out and a monthly cost.
Plan a GHK-Cu scheduleLast reviewed .